Recent Updates
Recently added Catalysts
SMTI Neutral Sentiment

In Vitro Compatibility Assessment of BIASURGE® Advanced Surgical Solution with Implantable Materials and Closure Technologies

Key Takeaway: The article discusses the in vitro compatibility assessment of BIASURGE® Advanced Surgical Solution with various implantable materials and closure technologies. It emphasizes the importance of this assessment for ensuring safety and effectiveness in surgical applications. The content is primarily informational and does not provide specific results or conclusions.
Price reaction · baseline $30.8 (2025-10-01 close) · hit pre-market · clean, no other SMTI news in the window
day 0 close · peak
+0.3%

Market Sentiment Analysis

Full Press Release Details

• Last Updated on February 10, 2026
Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute for manufacturer instructions nor create new product claims. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Please refer to our Terms of Use .

Related Posts

• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• About Sanara
• Board of Directors
• Surgical Products
• Code of Conduct
• Stock Quote
• Press Releases
• SEC Filings
© 2026 All Rights Reserved. Sanara MedTech Inc.
Last updated: Oct 2, 2025